Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Comply with the diagnostic criteria for COVID-19 in the "Diagnosis and Treatment Program for pneumonia caused by novel coronavirus infection (Trial Version 5)", meet the the criteria of severe and critical type; (2) Agree to participate in the study and the patient or legal guardian signs the informed consent form.
Exclusion criteria
Exclusion criteria: (1) It is difficult to administer to patients by oral or nasal feeding; (2) Pregnant women, as well as patients with other malignancies such as malignant tumors, mental illnesses, and patients who are not considered suitable for study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cure / mortality rate;Becomes negative time of COVID-19;TCM symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Indicators of inflammation (CRP, ESR);Blood gas analysis;Chest CT;Major symptom relief time; | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital